HKB's Mouse Autoimmune Hepatitis Models provide pharmaceutical researchers with robust platforms for investigating this serious autoimmune liver condition. Our validated rodent models utilize ConA injection, alpha-GalCer treatment, or genetic approaches to replicate key features of AIH including hepatocyte destruction, interface hepatitis, and autoimmune activation.